Diagnostic ability of %p2PSA and prostate health index for aggressive prostate cancer: a meta-analysis

Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS

(2013) Massimo Lazzeri et al.   BJU INTERNATIONAL

Serum Isoform [−2]proPSA Derivatives Significantly Improve Prediction of Prostate Cancer at Initial Biopsy in a Total PSA Range of 2–10 ng/ml: A Multicentric European Study

(2013) Massimo Lazzeri et al.   EUROPEAN UROLOGY

Head-to-Head Comparison of Prostate Health Index and Urinary PCA3 for Predicting Cancer at Initial or Repeat Biopsy

(2013) Vincenzo Scattoni et al.   JOURNAL OF UROLOGY

Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) Significantly Improve Prostate Cancer Detection at Initial Biopsy in a Total PSA Range of 2–10 ng/ml

(2013) Matteo Ferro et al.   PLoS One

Relationship of Chronic Histologic Prostatic Inflammation in Biopsy Specimens With Serum Isoform [-2]proPSA (p2PSA), %p2PSA, and Prostate Health Index in Men With a Total Prostate-specific Antigen of 4-10 ng/mL and Normal Digital Rectal Examination

(2013) Massimo Lazzeri et al.   UROLOGY

From prostate-specific antigen (PSA) to precursor PSA (proPSA) isoforms: a review of the emerging role of proPSAs in the detection and management of early prostate cancer

(2012) Satoshi Hori et al.   BJU INTERNATIONAL

Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers

(2012) Matteo Ferro et al.   CLINICA CHIMICA ACTA

Multicenter Evaluation of [-2]Proprostate-Specific Antigen and the Prostate Health Index for Detecting Prostate Cancer

(2012) C. Stephan et al.   CLINICAL CHEMISTRY

Comparative Assessment of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG Gene Fusion with the Serum [-2]Proprostate-Specific Antigen-Based Prostate Health Index for Detection of Prostate Cancer

(2012) C. Stephan et al.   CLINICAL CHEMISTRY

Serum Index Test %[-2]proPSA and Prostate Health Index are More Accurate than Prostate Specific Antigen and %fPSA in Predicting a Positive Repeat Prostate Biopsy

(2012) Massimo Lazzeri et al.   JOURNAL OF UROLOGY

Development and Internal Validation of a Prostate Health Index Based Nomogram for Predicting Prostate Cancer at Extended Biopsy

(2012) Giovanni Lughezzani et al.   JOURNAL OF UROLOGY

Prospective Multicenter Evaluation of the Beckman Coulter Prostate Health Index Using WHO Calibration

(2012) Stacy Loeb et al.   JOURNAL OF UROLOGY

Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy

(2012) Sisto Perdonà et al.   PROSTATE

Diagnostic significance of [−2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0–10.0 ng/mL range

(2012) Kazuto Ito et al.   WORLD JOURNAL OF UROLOGY

Prostate-Specific Antigen (PSA) Isoform p2PSA Significantly Improves the Prediction of Prostate Cancer at Initial Extended Prostate Biopsies in Patients with Total PSA Between 2.0 and 10 ng/ml: Results of a Prospective Study in a Clinical Setting

(2011) Giorgio Guazzoni et al.   EUROPEAN UROLOGY

Preoperative Prostate-Specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer

(2011) Giorgio Guazzoni et al.   EUROPEAN UROLOGY

A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range

(2011) William J. Catalona et al.   JOURNAL OF UROLOGY

A Prospective, Multicenter, National Cancer Institute Early Detection Research Network Study of [-2]proPSA: Improving Prostate Cancer Detection and Correlating with Cancer Aggressiveness

(2010) L. J. Sokoll et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Prostate-Specific Antigen (PSA) Isoform p2PSA in Combination with Total PSA and Free PSA Improves Diagnostic Accuracy in Prostate Cancer Detection

(2010) Flip H. Jansen et al.   EUROPEAN UROLOGY

[-2]Proenzyme Prostate Specific Antigen is More Accurate Than Total and Free Prostate Specific Antigen in Differentiating Prostate Cancer From Benign Disease in a Prospective Prostate Cancer Screening Study

(2010) Brian V. Le et al.   JOURNAL OF UROLOGY

Defining the optimal prostate-specific antigen threshold for the diagnosis of prostate cancer

(2009) Fritz H Schröder et al.   CURRENT OPINION IN UROLOGY

Prostate cancer mortality in screen and clinically detected prostate cancer: Estimating the screening benefit

(2009) Pim J. van Leeuwen et al.   EUROPEAN JOURNAL OF CANCER

[-2]Proenzyme Prostate Specific Antigen for Prostate Cancer Detection: A National Cancer Institute Early Detection Research Network Validation Study

(2008) Lori J. Sokoll et al.   JOURNAL OF UROLOGY

A [-2]proPSA-based artificial neural network significantly improves differentiation between prostate cancer and benign prostatic diseases

(2008) Carsten Stephan et al.   PROSTATE